196 related articles for article (PubMed ID: 14656696)
1. Increased serum CNTF level in patients with amyotrophic lateral sclerosis.
Iłzecka J
Eur Cytokine Netw; 2003; 14(3):192-4. PubMed ID: 14656696
[TBL] [Abstract][Full Text] [Related]
2. Serum level of CNTF is elevated in patients with amyotrophic lateral sclerosis and correlates with site of disease onset.
Laaksovirta H; Soinila S; Hukkanen V; Röyttä M; Soilu-Hänninen M
Eur J Neurol; 2008 Apr; 15(4):355-9. PubMed ID: 18353124
[TBL] [Abstract][Full Text] [Related]
3. Ciliary neurotrophic factor genotype does not influence clinical phenotype in amyotrophic lateral sclerosis.
Al-Chalabi A; Scheffler MD; Smith BN; Parton MJ; Cudkowicz ME; Andersen PM; Hayden DL; Hansen VK; Turner MR; Shaw CE; Leigh PN; Brown RH
Ann Neurol; 2003 Jul; 54(1):130-4. PubMed ID: 12838531
[TBL] [Abstract][Full Text] [Related]
4. The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. The ALS CNTF treatment study (ACTS) phase I-II Study Group.
Arch Neurol; 1996 Feb; 53(2):141-7. PubMed ID: 8639063
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid Flt3 ligand level in patients with amyotrophic lateral sclerosis.
Iłzecka J
Acta Neurol Scand; 2006 Sep; 114(3):205-9. PubMed ID: 16911350
[TBL] [Abstract][Full Text] [Related]
6. Decreased serum-soluble TRAIL levels in patients with amyotrophic lateral sclerosis.
Iłzecka J
Acta Neurol Scand; 2008 May; 117(5):343-6. PubMed ID: 17995989
[TBL] [Abstract][Full Text] [Related]
7. Plasma amino acids concentration in amyotrophic lateral sclerosis patients.
Iłzecka J; Stelmasiak Z; Solski J; Wawrzycki S; Szpetnar M
Amino Acids; 2003 Jul; 25(1):69-73. PubMed ID: 12836061
[TBL] [Abstract][Full Text] [Related]
8. Ciliary neurotrophic factor null alleles are not a risk factor for Charcot-Marie-Tooth disease, hereditary neuropathy with pressure palsies and amyotrophic lateral sclerosis.
Van Vught PW; Van Wijk J; Bradley TE; Plasmans D; Jakobs ME; Veldink JH; de Jong JM; Van den Berg LH; Baas F
Neuromuscul Disord; 2007 Dec; 17(11-12):964-7. PubMed ID: 17651970
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-1beta converting enzyme/Caspase-1 (ICE/Caspase-1) and soluble APO-1/Fas/CD 95 receptor in amyotrophic lateral sclerosis patients.
Iłzecka J; Stelmasiak Z; Dobosz B
Acta Neurol Scand; 2001 Apr; 103(4):255-8. PubMed ID: 11328198
[TBL] [Abstract][Full Text] [Related]
10. [Deficiency of human ciliary neurotropic factor (CNTF) is not causally related to amyotrophic lateral sclerosis (ALS)].
Takahashi R
Rinsho Shinkeigaku; 1995 Dec; 35(12):1543-5. PubMed ID: 8752458
[TBL] [Abstract][Full Text] [Related]
11. Creatine kinase activity in amyotrophic lateral sclerosis patients.
Iłzecka J; Stelmasiak Z
Neurol Sci; 2003 Nov; 24(4):286-7. PubMed ID: 14658051
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid vascular endothelial growth factor in patients with amyotrophic lateral sclerosis.
Iłzecka J
Clin Neurol Neurosurg; 2004 Sep; 106(4):289-93. PubMed ID: 15297002
[TBL] [Abstract][Full Text] [Related]
13. RANTES levels are elevated in serum and cerebrospinal fluid in patients with amyotrophic lateral sclerosis.
Rentzos M; Nikolaou C; Rombos A; Boufidou F; Zoga M; Dimitrakopoulos A; Tsoutsou A; Vassilopoulos D
Amyotroph Lateral Scler; 2007 Oct; 8(5):283-7. PubMed ID: 17852013
[TBL] [Abstract][Full Text] [Related]
14. EMMPRIN levels in serum of patients with amyotrophic lateral sclerosis.
Iłżecka J
Acta Neurol Scand; 2011 Dec; 124(6):424-8. PubMed ID: 21554254
[TBL] [Abstract][Full Text] [Related]
15. Serum-soluble receptor for advanced glycation end product levels in patients with amyotrophic lateral sclerosis.
Iłzecka J
Acta Neurol Scand; 2009 Aug; 120(2):119-22. PubMed ID: 19053950
[TBL] [Abstract][Full Text] [Related]
16. Granzymes A and B levels in serum of patients with amyotrophic lateral sclerosis.
Iłżecka J
Clin Biochem; 2011 Jun; 44(8-9):650-3. PubMed ID: 21349256
[TBL] [Abstract][Full Text] [Related]
17. Thyroid function in patients with amyotrophic lateral sclerosis.
Iłzecka J; Stelmasiak Z
Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):343-7. PubMed ID: 15315012
[TBL] [Abstract][Full Text] [Related]
18. Decreased cerebrospinal fluid cytochrome c levels in patients with amyotrophic lateral sclerosis.
Iłzecka J
Scand J Clin Lab Invest; 2007; 67(3):264-9. PubMed ID: 17454840
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-15 and interleukin-12 are elevated in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
Rentzos M; Rombos A; Nikolaou C; Zoga M; Zouvelou V; Dimitrakopoulos A; Alexakis T; Tsoutsou A; Samakovli A; Michalopoulou M; Evdokimidis I
Eur Neurol; 2010; 63(5):285-90. PubMed ID: 20407265
[TBL] [Abstract][Full Text] [Related]
20. Serum soluble OX40 in patients with amyotrophic lateral sclerosis.
Iłzecka J
Acta Clin Croat; 2012 Mar; 51(1):3-7. PubMed ID: 22919996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
